FSN.300.1 Influenza Hospitalizatin Surveillance Network (FluSurv-N

[NCEZID] Emerging Infections Program

FSN.300.1 FluSurv-NET CRF

OMB: 0920-0978

Document [pdf]
Download: pdf | pdf
Influenza
Hospitalization Surveillance Network (FluSurv-NET)
Case Report Form

U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
CENTERS FOR DISEASE CONTROL
AND PREVENTION
ATLANTA, GA 30329

FORM APPROVED
OMB NO. 0920-0978
FluSurv-NET Case ID:

COVID-NET Case ID:

RSV-NET Case ID:

A. Patient Data – THIS INFORMATION IS NOT SENT TO CDC
First Name:

Last Name:

Middle Name:

Address:

Chart Number:
Address Type:

City:

State:

Phone No. 2:

Zip Code:

Emergency Contact:

Phone No. 1:
Emergency Contact Phone:

PCP Clinic Name 1:

PCP Phone 1:

PCP Fax 1:

PCP Clinic Name 2

PCP Phone 2:

PCP Fax 2:

Site Use 1:

Site Use 2:

Site Use 3:

No PCP

CDCTrack:

B. Abstractor Information – THIS INFORMATION IS NOT SENT TO CDC
1. Abstractor Name:

2. Date of Abstraction:
C. Enrollment Information

1. Case Classification:
Surveillance Discharge Audit

2. State:

8. Race and/or Ethnicity (select all that apply):
American Indian or Alaska Native
Asian
Black or African American
Hispanic or Latino
Middle Eastern or North African
Multiracial, not otherwise specified
Native Hawaiian or Pacific Islander
White
Unknown

9. Was patient discharged
from any hospital within
1 week prior to the current
admission date?

13. Was patient transferred from another hospital?
Yes	
No	
Unknown

4. Case Type:
Pediatric
Adult

3. County:

Yes
No
Unknown

5. Date of Birth:

10. Type of Insurance (select all that apply):
Private
Medicare
Medicaid/state assistance program
Military
Indian Health Service
Incarcerated
Uninsured
Unknown
Other, specify:

13a. Transfer Hospital ID:

6. Age:
7. Sex:
Years
Male
Months (if < 1 yr)
Female
Days (if < 1 month)
11. Pregnant? (15-49 years of age only):
Yes	
No/Unknown
Not applicable
(male/pregnant outside of applicable age range)

12. Hospital ID Where Patient Treated:
12a. Admission Date:
12b. Discharge Date:

13b. Transfer Hospital Admission Date:
13c. Transfer Date:

14. Where did the patient reside at the time of hospitalization? (Indicate TYPE of residence.)
Private residence
Private residence with services
Homeless/Shelter/Temporary housing
Nursing home/Skilled nursing facility

Substance abuse treatment center
Hospitalized at birth
Rehabilitation facility
Corrections facility

Hospice
Assisted living/Residential care
LTACH
Group/Retirement home

 Psychiatric/Behavioral
Health Facility
Other long term care facility
Unknown
Other, specify:

14a. If resident of a facility indicate NAME of facility:
Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct
or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number. Send comments
regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information
Collection Request Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0978).

06/06/2024

Page 1 of 9

FSN 300.1
CS349395-B

Case ID:
D. Influenza Testing Results (can add up to 4 test results in database)
1. Test 1:

Rapid Antigen
Standard/Rapid Molecular Assay

Viral Culture
Fluorescent Antibody

1a. Result:

Flu A (no subtype)
2009 H1N1
H1, Unspecified

Flu A, Unsubtypable
Flu B (no lineage)
Flu B, Victoria

H1, Seasonal
H1
H3

1b. Specimen collection date:

Method Unknown
Flu B, Yamagata
Flu A & B
Flu A/B (not distinguished)

1c. Specimen ID:

2. Test 2:

Rapid Antigen
Standard/Rapid Molecular Assay

Viral Culture
Fluorescent Antibody

2a. Result:

Flu A (no subtype)
2009 H1N1
H1, Unspecified

Flu A, Unsubtypable
Flu B (no lineage)
Flu B, Victoria

H1, Seasonal
H1
H3

2b. Specimen collection date:
Rapid Antigen
Standard/Rapid Molecular Assay

Viral Culture
Fluorescent Antibody

3a. Result:

Flu A (no subtype)
2009 H1N1
H1, Unspecified

Flu A, Unsubtypable
Flu B (no lineage)
Flu B, Victoria

H1, Seasonal
H1
H3

3b. Specimen collection date:

Other, please specify:

1d. Testing facility ID:
Method Unknown
Flu B, Yamagata
Flu A & B
Flu A/B (not distinguished)

2c. Specimen ID:

3. Test 3:

Unknown Type
Negative
H3N2v

Unknown Type
Negative
H3N2v

Other, please specify:

2d. Testing facility ID:
Method Unknown
Flu B, Yamagata
Flu A & B
Flu A/B (not distinguished)

3c. Specimen ID:

Unknown Type
Negative
H3N2v

Other, please specify:

3d. Testing facility ID:

E. Other Interventions and ICU (For Questions 1-5, select the highest level of oxygen support received)
1. BiPAP or CPAP?

Yes	

No	

2. High flow nasal cannula (e.g., Vapotherm)?

Unknown

4. ECMO?

Yes	

No	

Unknown

3. Invasive mechanical ventilation?

Yes	

5. Supplemental Oxygen?

Yes	
No	
Unknown
6. Renal Replacement Therapy (RRT) or Dialysis?
Includes Peritoneal Dialysis (PD), Hemodialysis (HD), Continuous Venovenous Hemofiltration (CVVH),
Continuous Venovenous Hemodialysis (CVVHD), and Slow Continuous Ultrafiltration (SCUF)

Yes	

No

Unknown

No	

7. Was the patient admitted to an intensive care unit (ICU)?
7a. Date of 1st ICU Admission:

Unknown

Yes	
Unknown

No	

Yes	

No	

Unknown

Unknown
7b. Date of 1st ICU Discharge:

Unknown

F. Outcome
1. What was the outcome of the patient upon discharge?

Alive	

Died during hospitalization	

Unknown

2. If patient discharged alive, please indicate to where:
Private residence
Private residence with services
Homeless/Shelter/Temporary housing
Nursing home/Skilled nursing facility
Substance abuse treatment center
Rehabilitation facility

Corrections facility
Hospice
Assisted living/Residential care
LTACH
Group/Retirement home
Psychiatric/Behavioral Health Facility

Other long term care facility
Against medical advice (AMA)
Discharged to another hospital
Other, specify:
Unknown

3. Additional notes regarding discharge:

06/06/2024

Page 2 of 9

FSN 300.1
CS349395-B

Case ID:
G. Admission and Patient History
1. Reason for admission:
Psychiatric admission needing acute medical care
Newborn/Hospitalized at birth
Trauma

Influenza-related illness
OB/Labor and delivery admission
Inpatient surgery/procedures

Other, specify:
Unknown

2. Acute signs/symptoms present at admission (began or worsened within 2 weeks prior to admission) (Select all that apply):
Non-respiratory symptoms
Abdominal pain
Altered mental status/
confusion

None of the below signs/symptoms

Anosmia/Decreased smell
Chest pain/tightness
Conjunctivitis

Diarrhea
Dysgeusia/Decreased taste
Fatigue

Fever/chills
Headache
Muscle aches/myalgias

Cough
Hemoptysis/bloody
sputum

Shortness of breath/
respiratory distress/hypoxia
Sore throat

URI/ILI
Wheezing

Hypothermia
Inability to eat/poor feeding
Irritability/fussiness/
excess crying

 ethargy/decreased activity
L
Nasal flaring/grunting/
retractions

Stridor/decreased
vocalization
Tachypnea/increased work
of breathing

Nausea/vomiting
Rash
Seizures

Respiratory symptoms
Chest congestion
Congested/runny nose
For cases < 12 years
Apnea
Cyanosis
Dehydration/decreased
urine output

3. Date of onset of acute respiratory symptoms (within 2 weeks before a positive test):
4. Height:

Inch	
Cm
Unknown

7. Smoker (tobacco) (for patients > 12 years):
Current	

Former	

No/Unknown

9. Alcohol misuse (for patients > 12 years):
Current	
Former	
No/Unknown

Unknown	
Lbs	
Kg
Unknown

5. Weight:

Not applicable

6. BMI: (non-pregnant cases and cases ≥ 2 years only)

Unknown

8. Environmental tobacco smoke exposure (for pediatric patients ≤ 12 years):
Yes	

No	

Unknown

10. Substance misuse (for patients > 12 years):
Current	

Former	

No/Unknown

11. Substance Misuse Type or Route (current use only) (Select all that apply) :
Cocaine
IVDU
Opioids
12. Code status on admission:

06/06/2024

Polysubstance abuse - not otherwise specified
Methamphetamines
Marijuana
Full code	

DNR/DNI/CMO	

Other, specify:
Unknown

Unknown

Page 3 of 9

FSN 300.1
CS349395-B

Case ID:
H. Underlying Medical Conditions
1. Did the patient have any of the following pre-existing medical conditions? (Select all that apply):	
1a. Asthma/Reactive Airway Disease:	

Yes	

No/Unknown

1b. Chronic Lung Disease:	
Yes	
No/Unknown
Active Tuberculosis (TB)
Asbestosis
Bronchiectasis
Bronchiolitis obliterans
Chronic bronchitis
Chronic respiratory failure
Cystic fibrosis (CF)
Emphysema/Chronic obstructive pulmonary disease (COPD)
Interstitial lung disease (ILD)
Obstructive sleep apnea (OSA)
Oxygen (O2) dependent
Pulmonary fibrosis
Restrictive lung disease
Sarcoidosis
1c. Diabetes Mellitus (DM):	

Yes	

No/Unknown

1d. Chronic Metabolic Disease:	
Yes	
No/Unknown
Adrenal Disorders (Addison’s disease, adrenal insufficiency,
Cushing syndrome, congenital adrenal hyperplasia)
Glycogen or other storage diseases (See list)
Hyper/Hypo- function of pituitary gland
Inborn errors of metabolism (See list)
Metabolic syndrome
Parathyroid dysfunction (hyperparathyroidism, hypoparathyroidism)
Thyroid dysfunction (Grave’s disease, Hashimoto’s disease, hyperthyroidism,
hypothyroidism)
1e.Blood Disorders/Hemoglobinopathy:	
Yes	
No/Unknown
Alpha thalassemia
Aplastic anemia
Beta thalassemia
Coagulopathy (Factor V Leiden, Von Willebrand disease (VWD), see list)
Hemoglobin S-beta thalassemia
Leukopenia
Myelodysplastic syndrome (MDS)
Neutropenia
Pancytopenia
Polycythemia vera
Sickle cell disease
Splenectomy/Asplenia
Thrombocytopenia

06/06/2024

Yes	

1f. Hypertension (HTN):	

No	

Unknown
Yes	

No/Unknown

1g. Cardiovascular Disease:	
Yes	
No/Unknown
Aortic aneurysm (AAA), history of
Aortic/Mitral/Tricuspid/Pulmonic valve replacement, history of
Aortic regurgitation (AR)
Aortic stenosis (AS)
Atherosclerotic cardiovascular disease (ASCVD)
Atrial fibrillation (AFib)
Atrioventricular (AV) blocks
Automated implantable devices (AID/AICD)/Pacemaker
Bundle branch block (BBB/RBBB/LBBB)
Cardiomyopathy
Carotid stenosis
Cerebral vascular accident (CVA)/Incident/Stroke, history of
Congenital heart disease (Specify)
Atrial septal defect
Patent Ductus Arteriosus (PDA)
Pulmonic stenosis
Tetralogy of Fallot
Ventricular septal defect
Other, specify:
Coronary artery bypass grafting (CABG), history of
Coronary artery disease (CAD)
Deep vein thrombosis (DVT), history of
Heart failure/Congestive heart failure (CHF)
Myocardial infarction (MI), history of
Mitral regurgitation (MR)
Mitral stenosis (MS)
Peripheral artery disease (PAD)
Peripheral vascular disease (PVD)
Pulmonary embolism (PE), history of
Pulmonary hypertension (PHTN)
Pulmonic regurgitation
Pulmonic stenosis
Transient ischemic attack (TIA), history of
Tricuspid regurgitation (TR)
Tricuspid stenosis
Ventricular fibrillation (VF, VFib), history of
Ventricular tachycardia (VT, VTach), history of

Page 4 of 9

FSN 300.1
CS349395-B

Case ID:
H. Underlying Medical Conditions (continued)
1h. Neurologic Disorder:	
Yes	
Amyotrophic lateral sclerosis (ALS)
Cerebral palsy
Cognitive dysfunction
Dementia/Alzheimer’s disease
Developmental delay
Down syndrome/Trisomy 21
Edward’s syndrome/Trisomy 18
Epilepsy/seizure/seizure disorder
Mitochondrial disorder (See list)
Multiple sclerosis (MS)
Muscular dystrophy (See list)
Myasthenia gravis (MG)
Neural tube defects/Spina bifida (See list)
Neuropathy
Parkinson’s disease
Plegias/Paralysis/Quadriplegia
Scoliosis/Kyphoscoliosis
Traumatic brain injury (TBI), history of

No/Unknown

1i. History of Guillain-Barre Syndrome:	

No/Unknown

Yes	

1j. Immunocompromised Condition:	
Yes	
No/Unknown
AIDS or CD4 count < 200
Complement deficiency (See list)
Graft vs. host disease (GVHD)
HIV infection
Immunoglobulin deficiency/immunodeficiency (See list)
Immunosuppressive therapy
(within the 12 months previous to admission) (see instructions):
If yes, for what condition?
Leukemia*
Lymphoma/Hodgkins/Non-Hodgkins (NHL)*
Metastatic cancer*
Multiple myeloma*
Solid organ malignancy*
If yes, which organ?
Steroid therapy (within 2 weeks of admission) (see instructions)
Transplant, hematopoietic stem cell (bone marrow transplant (BMT),
peripheral stem cell transplant (PSCT)), history of
Transplant, solid organ (SOT), history of
*Current/in treatment or diagnosed in last 12 months
1k. Renal Disease	
Yes	
No/Unknown
Chronic kidney disease (CKD)/chronic renal insufficiency (CRI)
Dialysis (HD)
End stage renal disease (ESRD)
Glomerulonephritis (GN)
Nephrotic syndrome
Polycystic kidney disease (PCKD)
1l Any Obesity:	
Yes	
Obese
Severely/morbidly obese (ADULTS ONLY)

No/Unknown

1m. Post-partum (two weeks or less):	

No/Unknown

06/06/2024

Yes	

1n. Gastrointestinal/Liver Disease
(Do Not Record GERD):	
Yes	
No/Unknown
Alcoholic hepatitis
Autoimmune hepatitis
Barrett’s esophagitis
Chronic liver disease
Chronic pancreatitis
Cirrhosis/End stage liver disease (ESLD)
Crohn’s disease
Esophageal varices
Esophageal strictures
Hepatitis B, chronic (HBV)
Hepatitis C, chronic (HCV)
Non-alcoholic fatty liver disease (NAFLD)/NASH
Ulcerative colitis (UC)
1o. Rheumatologic/Autoimmune/Inflammatory
Conditions (Do Not Record OA):	
Yes	
Ankylosing spondylitis
Dermatomyositis
Juvenile idiopathic arthritis
Kawasaki disease
Microscopic polyangiitis
Polyarteritis nodosum (PAN)
Polymyalgia rheumatica
Polymyositis
Psoriatic arthritis
Rheumatoid arthritis (RA)
Systemic lupus erythematosus (SLE)/Lupus
Systemic sclerosis
Takayasu arteritis
Temporal/Giant cell arteritis
Vasculitis, other (See list)
1p. Mental Health Conditions:	
Bipolar disorder
Depression
Schizophrenia spectrum disorder

No/Unknown

Yes	

No/Unknown

1q. Other:	
Yes	
Bedbound
Feeding tube dependent (PEG, see list)
Trach dependent/Vent dependent
Wheelchair dependent
Other, specify:

No/Unknown

1r. PEDIATRIC CASES ONLY
Abnormality of airway (see instructions)
Chronic lung disease of prematurity/Bronchopulmonary dysplasia (BPD)
History of febrile seizures
Long term aspirin therapy
Premature (gestational age < 37 weeks at birth for patients < 2 years)
If yes, specify gestational age at birth in weeks:
Unknown gestational age at birth

Page 5 of 9

FSN 300.1
CS349395-B

Case ID:
I. Viral Pathogens
1.Was patient tested for any of the following viral respiratory pathogens within 14 days prior to admission or ≤3 days after admission?

Yes	

1a. RSV

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1b. Coronavirus SARS-CoV-2

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1c. Adenovirus

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1d. Parainfluenza 1

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1e. Parainfluenza 2

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1f. Parainfluenza 3

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1g. Parainfluenza 4

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1h. Human metapneumovirus

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1i. Rhinovirus/Enterovirus

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1j. Coronavirus 229E

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1k. Coronavirus HKU1

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1l. Coronavirus NL63

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1m. Coronavirus OC43

Yes, positive

Yes, negative

Not tested/Unknown

Date:

1n. Coronavirus (not further specified)

Yes, positive

Yes, negative

Not tested/Unknown

Date:

No	

Unknown

J. Influenza Treatment (can add up to 4 treatment courses in database)
1. Did the patient receive treatment for influenza?
1a. Treatment 1:

Baloxavir marboxil (Xofluza)
Oseltamivir (Tamiflu)

1b. Start date:
2a. Treatment 2:

Yes	

No	

Unknown
Peramivir (Rapivab)
Zanamivir (Relenza)

Other, specify:
Unknown

Peramivir (Rapivab)
Zanamivir (Relenza)

Other, specify:
Unknown

Unknown
Baloxavir marboxil (Xofluza)
Oseltamivir (Tamiflu)

2b. Start date:

Unknown

3. Vasopressor use?
Yes	
No	
Unknown
(Common vasopressors are Dobutamine, Dopamine, Epinephrine, Milrinone, Neosynephrine, Norepinephrine, Vasopressin)
4. Additional Treatment Comments:
K. Chest X-ray – Based on radiology report only
1. Was a chest x-ray taken during the first 3 days of admission (for patients ≤17 years)?

06/06/2024

Page 6 of 9

Yes	

No	

Unknown

FSN 300.1
CS349395-B

Case ID:
L. Discharge Summary
1. Did the patient have any of the following new diagnoses at discharge? (select all that apply)

No discharge summary available

Acute complication of sickle cell	

Yes	

No/Unknown

Disseminated intravascular coagulation (DIC)	

Yes	

No/Unknown

Acute encephalopathy/encephalitis	

Yes	

No/Unknown

Guillain-Barre syndrome	

Yes	

No/Unknown

Acute liver failure	

Yes	

No/Unknown

Hemophagocytic syndrome	

Yes	

No/Unknown

Acute myocardial infarction	

Yes	

No/Unknown

Invasive pulmonary aspergillosis	

Yes	

No/Unknown

Acute myocarditis	

Yes	

No/Unknown

Kawasaki disease	

Yes	

No/Unknown

Acute renal failure/acute kidney injury	

Yes	

No/Unknown

No/Unknown

Yes	

No/Unknown

Acute respiratory failure	

Yes	

No/Unknown

Mucormycosis	
Multisystem inflammatory syndrome in
children (MIS-C) or adults (MIS-A)	

Yes	

Acute respiratory distress syndrome (ARDS)	

Yes	

No/Unknown

Asthma exacerbation	

Yes	

No/Unknown

Other thrombosis/embolism/coagulopathy	

Yes	

No/Unknown

Atrial fibrilation (Afib) new-onset
or paroxysmal/chronic	

Pneumonia	

Yes	

No/Unknown

Yes	

No/Unknown

Pulmonary embolism (PE)	

Yes	

No/Unknow

Bacteremia	

Yes	

No/Unknown

Reye’s Syndrome	

Yes	

No/Unknown

Yes	

No/Unknown

Bronchiolitis	

Yes	

No/Unknown

Rhabdomyolysis	

Bronchitis	

Yes	

No/Unknown

Sepsis	

Yes	

No/Unknown

Cardiac arrest	

Yes	

No/Unknown

Seizures	

Yes	

No/Unknown

Yes	

No/Unknown

Chronic lung disease of prematurity/BPD	

Yes	

No/Unknown

Stroke (CVA)	

Congestive heart failure exacerbation	

Yes	

No/Unknown

Supraventricular tachycardia (SVT)	

Yes	

No/Unknown

COPD exacerbation	

Yes	

No/Unknown

Toxic shock syndrome (TSS)	

Yes	

No/Unknown

Deep vein thrombosis (DVT)	

Yes	

No/Unknown

Ventricular fibrillation (Vfib)	

Yes	

No/Unknown

Diabetic ketoacidosis	

Yes	

No/Unknown

Ventricular tachycardia (V-tach)	

Yes	

No/Unknown

M. ICD-10-CM Discharge Diagnoses (to be recorded in order of appearance)
ICD-10-CM codes available?	

Yes	

No

1.

4.

7.

2.

5.

8.

3.

6.

9.

N. Pregnancy Information - To be completed for pregnant women only
1. Total # of pregnancies to date as of date of admission
(Gravida, G):
Unknown

2. Total # of pregnancies to date that resulted in a live birth
as of date of admission (Parity, P):
Unknown

4. Specify gestational age in weeks as of date of admission:	
If gestational age in weeks unknown, specify trimester of pregnancy:

3. Specify total # of fetuses for current pregnancy
as of date of admission
1	
2	
3	
>3
Unknown

Unknown
1st (0 to 13 6/7 weeks)
2nd (14 0/7 to 27 6/7 weeks)

3rd (28 0/7 to end)
Unknown

5. Pregnancy complications during current pregnancy? (Select all that apply):
None
Gestational diabetes
6. Indicate pregnancy status at discharge or death:	

Pre-eclampsia
Pregnancy-induced hypertension (PIH)
Still pregnant	

No longer pregnant	

6a. If patient was pregnant on admission but no longer pregnant at discharge, indicate
pregnancy outcome at discharge. (If multiple fetuses, indicate outcome at discharge
for each fetus in the database separately.)
Healthy newborn
(if Healthy newborn, ill newborn or infant died, go to 6b.)
Ill newborn
Infant died
Miscarriage (intrauterine death at < 20 weeks GA)
Stillbirth (intrauterine death at ≥ 20 weeks GA)
Abortion
Unknown

}

6c. If no longer pregnant, indicate date of delivery or end of pregnancy:	

06/06/2024

Intrauterine growth restriction (IUGR)
Unknown
Unknown

6b. Pre-term live birth? (< 37 weeks GA)
Yes	
No
Unknown

Preterm delivery, gestational age in weeks:

Unknown

Page 7 of 9

FSN 300.1
CS349395-B

Case ID:
O. Influenza Vaccination History
Specify vaccination status and date(s) by source:
No
Unknown

Yes, full date known
Yes, specific date unknown

1. Medical Chart:
1a. If yes, specify dosage date information:	

Date Unknown

1b. If patient < 9 yrs, specify vaccine type:	

Injected Vaccine	

2. Vaccine Registry:

Yes, full date known
Yes, specific date unknown

Nasal Spray/FluMist	

Injected Vaccine	

3. Primary Care Provider /LTCF:

Yes, full date known
Yes, specific date unknown

Not Checked
Unsuccessful Attempt

Nasal Spray/FluMist	

Combination of both	

No
Unknown

3a. If yes, specify dosage date information:	

Unknown type

Not Checked
Unsuccessful Attempt

Date Unknown

3b. If patient < 9 yrs, specify vaccine type:	

Injected Vaccine	

4. Interview:

Yes, full date known
Yes, specific date unknown

Nasal Spray/FluMist	

Combination of both	

No
Unknown

4a. If yes, specify dosage date information:	

Unknown type

Not Checked
Unsuccessful Attempt

Date Unknown
Injected Vaccine	

Nasal Spray/FluMist	

Combination of both	

5. If patient < 9 yrs, did patient receive any seasonal influenza vaccine previous seasons?	

Yes	

No	

Unknown

6. If patient < 9 yrs, did patient receive 2nd influenza vaccine in current season?	

Yes	

No	

Unknown

6a. If yes, specify 2nd dosage date information:		

Unknown type

Date Unknown

2b. If patient < 9 yrs, specify vaccine type:	

4b. If patient < 9 yrs, specify vaccine type:	

Combination of both	

No
Unknown

2a. If yes, specify dosage date information:	

Patient
Proxy

Not Checked
Unsuccessful Attempt

Unknown type

Date Unknown
P. Additional Comments

06/06/2024

Page 8 of 9

FSN 300.1
CS349395-B

Case ID:
R. COVID-19 Vaccine History (Additional products will be listed in the database as FDA authorization/emergency use authorization received)
1. Vaccine registry:
Registry reviewed
Registry available but not reviewed (specify):
Registry not available for review

2. COVID-19 vaccine doses received (For cases ≥ 6 years old, record all doses of COVID-19 vaccine received on/after August 31, 2022. For cases < 6 years old, record all available
doses of COVID-19 vaccine)
FOR COVID-NET CASE PATIENTS ≥ 6 YEARS OLD:
Dose Date

Dose Product

Month Day

Vaccines available as of Fall 2023
2023 Pfizer-BioNTech COVID-19 Vaccine, Monovalent (XBB.1.5)
2023 Moderna COVID-19 Vaccine, Monovalent (XBB.1.5)

Unk.

Unk.

Year
Unk.

Dose Source
Registry

Vaccines available prior to Fall 2023
 fizer-BioNTech COVID-19 Vaccine, Bivalent (COMIRNATY/ bivalent BNT162b2 -orP
Original and Omicron BA.4/BA.6)
Moderna COVID-19 Vaccine, Bivalent (mRNA-1273.214)
Janssen Pharmaceuticals (JNJ-78436735)
Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373, Covovax)
AstraZeneca (AZD1222)
Unknown
Other, specify:

FOR COVID-NET CASE-PATIENTS ≥ 6 MONTHS- <6 YEARS OLD:
Dose Date

Dose Product

Month Day

Vaccines available as of Fall 2023
2023 Pfizer-BioNTech COVID-19 Vaccine, Monovalent (XBB.1.5)
2023 Moderna COVID-19 Vaccine, Monovalent (XBB.1.5)

Unk.

Unk.

Year
Unk.

Dose Source
Registry

Vaccines available prior to Fall 2023
Pfizer-BioNTech COVID-19 Vaccine, Bivalent (COMIRNATY)
Moderna COVID-19 Vaccine, Bivalent (Spikevax)
Pfizer-BioNTech COVID-19 Vaccine, Monovalent or (COMIRNATY/ Monovalent BNT162b2)
Moderna COVID-19 Vaccine, Monovalent (Spikevax, mRNA-1273)
Unknown
Other, specify:

Page 9 of 9

CS341635-A


File Typeapplication/pdf
Subject2024–2025 Influenza Hospitalization Surveillance Network (FluSurv-NET) Case Report Form
AuthorCenters for Disease Control and Prevention
File Modified2024-06-11
File Created2024-06-11

© 2024 OMB.report | Privacy Policy